Faster pancreas tumor diagnosis with AI
Part of Digestive system clinical trials.
This trial uses a new, faster method to diagnose solid pancreatic tumors during an endoscopic ultrasound procedure. It combines rapid staining of cells with artificial intelligence to give a quick and accurate diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid (not fluid-filled) mass in your pancreas, found on a scan like ultrasound, CT, or MRI.
- You are not taking blood thinners that you cannot safely pause for the procedure.
- You do not have a bleeding disorder (e.g., low platelets or high INR).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new computer (deep-learning) system to help analyze pictures from an endoscopic ultrasound scan of the pancreas. It may improve how the scan is done or interpreted, depending on study results.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
This trial tests a new approach that combines a special biopsy needle with immediate on-site checking to better diagnose solid pancreas masses. It may help get a clearer diagnosis in one procedure.
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
This study uses blood taken from a vein to build and check diagnostic models for pancreatic cancer. It may help doctors identify pancreatic cancer more accurately in people who have a suspected mass on imaging.
Hear when a new Pancreatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.